Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - Boston Therapeutics, Inc. | ea147192-8k_bostonther.htm |
Exhibit 3.1
CERTIFICATE OF AMENDMENT TO THE
CERTIFICATE OF INCORPORATION OF
BOSTON THERAPEUTICS, INC.
Boston Therapeutics, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY:
1. This Certificate of Amendment (the “Certificate of Amendment”) amends the provisions of the Corporation’s Certificate of Incorporation, as amended (the “Certificate of Incorporation”).
2. ARTICLE 1 of the Certificate of Incorporation is hereby amended and restated in its entirety as follows:
| FIRST | . The name of the corporation is Nanomix Holdings, Inc. |
3. This amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.
4. All other provisions of the Certificate of Incorporation shall remain in full force and effect.
5. The effective date of the Certificate of Amendment is September 14, 2021.
IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by David Ludvigson, its CEO, this 2nd day of September, 2021.
| By: | /s/ David Ludvigson | |
| Name: | David Ludvigson | |
| Title: | Chief Executive Officer |